Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...

Relapsing MS is the most common form of multiple sclerosis. About 85% of people with MS at least start out with a relapsing form. A relapse is a problem that comes on fairly rapidly, not abruptly ...

Up to 85% of the people who receive a diagnosis of the neurodegenerative disorder multiple sclerosis (MS) have the ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

Neuraxpharm Ireland, part of Neuraxpharm Group, a leading European speciality pharmaceutical company focused on the treatment ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

The following is a summary of “Cost–consequence analysis of early vs. delayed natalizumab use in highly active ...

I'm Dr. John Whyte, the Chief Medical Officer at WebMD. Today, I want to talk a little bit about relapsing multiple sclerosis, particularly about the loss of cognitive function in patients.

[20] In a 36-week Phase II study of relapsing MS, teriflunomide-treated patients showed a statistically significant decrease in active MRI lesions, and fewer subjects receiving high-dose ...